ABIN152250
antibody from antibodies-online
Targeting: TP53
LFS1, p53
Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [2]
- Immunoprecipitation [3]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN152250 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tumor Protein P53 (TP53) antibody
- Antibody type
- Monoclonal
- Description
- Protein G purified
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- Pab1801
- Vial size
- 100 μL
- Storage
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Identification and comparative analyses of myocardial miRNAs involved in the fetal response to maternal obesity.
Oncogenic functions of secreted Frizzled-related protein 2 in human renal cancer.
COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas.
Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue.
Immunohistochemical analysis of p53 expression in malignant lymphomas.
P53 expression in breast cancer.
Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.
Maloyan A, Muralimanoharan S, Huffman S, Cox LA, Nathanielsz PW, Myatt L, Nijland MJ
Physiological genomics 2013 Oct 1;45(19):889-900
Physiological genomics 2013 Oct 1;45(19):889-900
Oncogenic functions of secreted Frizzled-related protein 2 in human renal cancer.
Yamamura S, Kawakami K, Hirata H, Ueno K, Saini S, Majid S, Dahiya R
Molecular cancer therapeutics 2010 Jun;9(6):1680-7
Molecular cancer therapeutics 2010 Jun;9(6):1680-7
COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas.
Dornan D, Bheddah S, Newton K, Ince W, Frantz GD, Dowd P, Koeppen H, Dixit VM, French DM
Cancer research 2004 Oct 15;64(20):7226-30
Cancer research 2004 Oct 15;64(20):7226-30
Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue.
Porter PL, Gown AM, Kramp SG, Coltrera MD
The American journal of pathology 1992 Jan;140(1):145-53
The American journal of pathology 1992 Jan;140(1):145-53
Immunohistochemical analysis of p53 expression in malignant lymphomas.
Said JW, Barrera R, Shintaku IP, Nakamura H, Koeffler HP
The American journal of pathology 1992 Dec;141(6):1343-8
The American journal of pathology 1992 Dec;141(6):1343-8
P53 expression in breast cancer.
Cattoretti G, Rilke F, Andreola S, D'Amato L, Delia D
International journal of cancer 1988 Feb 15;41(2):178-83
International journal of cancer 1988 Feb 15;41(2):178-83
Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.
Banks L, Matlashewski G, Crawford L
European journal of biochemistry 1986 Sep 15;159(3):529-34
European journal of biochemistry 1986 Sep 15;159(3):529-34
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IP
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IP
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IP
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC